Antibody-drug conjugates ace the tolerability test
- 1 August 2008
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 26 (8), 884-885
- https://doi.org/10.1038/nbt0808-884
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexNature Biotechnology, 2008
- Antibody-Drug Conjugates for Cancer TherapyThe Cancer Journal, 2008
- Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachmentProtein Engineering, Design and Selection, 2006
- Drug-conjugated monoclonal antibodies for the treatment of cancerCurrent Opinion in Pharmacology, 2005
- Arming antibodies: prospects and challenges for immunoconjugatesNature Biotechnology, 2005
- Reduction−Alkylation Strategies for the Modification of Specific Monoclonal Antibody DisulfidesBioconjugate Chemistry, 2005
- Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug ConjugateClinical Cancer Research, 2004
- Tumour-targeted chemotherapy with immunoconjugates of calicheamicinExpert Opinion on Biological Therapy, 2004